
The August Special Report emphasizes the urgent need for action beyond diversity in psychiatry, addressing systemic racism's profound impact on Black mental health.

The August Special Report emphasizes the urgent need for action beyond diversity in psychiatry, addressing systemic racism's profound impact on Black mental health.

Discover effective strategies for treating borderline personality disorder without intensive therapy, focusing on empowerment, structure, and human connection.


Altimmune's pemvidutide gains FDA Fast Track designation for alcohol use disorder.

H. Steven Moffic, MD, examines the psychological dynamics of hubris, humiliation, and revenge in global conflicts.

Explore effective strategies for managing narcolepsy, including personalized treatment plans, medication options, and lifestyle interventions for improved patient outcomes.

New research reveals how past trauma influences brain responses to stress, highlighting the importance of neural connectivity in mental health and coping strategies.

Nearly half of catatonia patients relapse within two years, highlighting the need for effective long-term management strategies and potential benefits of antipsychotics.

BioXcel Therapeutics advances BXCL501 for outpatient treatment of agitation in bipolar disorder and schizophrenia, receiving positive FDA feedback in its pre-sNDA meeting discussion.

Explore the intersection of Taylor Swift's music, relationships, and their impact on mental well-being in today's society.

FDA approves Tonmya, a groundbreaking fibromyalgia treatment, offering hope for pain relief after 15 years without new options.

Antidepressant treatment for late-life depression enhances cognitive functions like memory and learning, linking symptom relief to cognitive improvement.

AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.

What are the cultural implications of President Trump's Kennedy Center Honors selections?

Psychodynamically-informed pharmacotherapy is much more than “prescribing.”

Current crises threaten children's health and mental well-being globally, highlighting the urgent need for action and support from psychiatry and society.

The complexities of Huntington disease can pose challenges for diagnosis. Let's take a look at its neuropsychiatric symptoms and the need for comprehensive treatment strategies.

"Tonight their eyes meet with the spirit of sacred music..."

Discover the complexities of sleep-related eating disorder, its symptoms, triggers, and effective treatments for better sleep health.

Dysphoric milk ejection reflex (D-MER) causes brief emotional distress during breastfeeding, often misdiagnosed as postpartum depression, requiring better awareness and support.

Hurricane Katrina's legacy highlights the urgent need for trauma-informed mental health care in disaster recovery, addressing PTSD and long-term emotional impacts.

PharmaTher's KETARx gains FDA approval, paving the way for innovative ketamine treatments in pain management and mental health disorders.

Effective strategies for managing child agitation focus on individualized care, multidisciplinary support, and proactive interventions to ensure safety and calm.

Researchers uncover how serotonin receptor 5-HT1A influences drug interactions, paving the way for faster, targeted psychiatric treatments.

New executive order targets homeless individuals through institutionalization, raising concerns about stigma and lack of real solutions for vulnerable populations.

Explore the intersection of psychiatry and politics as H. Steven Moffic, MD, reflects on Canadian unity and the challenges facing mental health services today.

Explore the evolution and therapeutic potential of GLP-1, a key incretin in diabetes management and weight loss solutions.

UK study of "active ingredients" in early psychosis intervention is applicable to US programs, according to the codirector of Stanford's INSPIRE Clinic.

NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.

Let's examine the mental health challenges faced by Native Americans and First Nations, highlighting historical trauma and the need for reparative actions.